RCKT: Multiplikator P/S Rocket Pharmaceuticals Inc
The P/S multiple dynamics highlight the efficiency of the complex genetic material logistics that support margins for Rocket Pharmaceuticals (RCKT). However, the absence of current revenue due to the research stage creates financial uncertainty. Patents for the treatment of rare pathologies serve as a defense, creating barriers for competitors. The latest reading currently stands at , which allows for an assessment of market expectations regarding the company's future sales.
Rincian analitis perusahaan Rocket Pharmaceuticals Inc (RCKT)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Rocket Pharmaceuticals|RCKT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Rocket Corp|RCKT - Gunggung utang perusahaan|Utang-utang marang nilai buku Rocket Pharmaceuticals Inc|RCKT - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Rocket Pharmaceuticals|Rasio likuiditas perantara rocketpharma.com
- informasi bathi lan kelipatan valuasi:
RCKT - Bathi resik|Prakiraan bathi perusahaan Rocket Pharmaceuticals|RCKT - Pangali P/E|Prakiraan rega marang bathi Rocket Pharma|RCKT - Pangali PEG|Pangali EV/EBITDA Rocket Pharmaceuticals Inc|RCKT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Rocket Pharmaceuticals|RCKT - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan rocketpharma.com|RCKT - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Rocket Pharmaceuticals
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:RCKT - rocketpharma.com
The price-to-sales ratio reflects the proportion of market capitalization to revenue, where chart volatility is driven exclusively by price fluctuations against static reporting data. For Rocket Pharmaceuticals (RCKT), whose gene therapy developments are protected by humanitarian status and the stability of US regulations, analyzing this indicator allows for the timely identification of the risk of overpaying for the asset amid price growth.
Karo sapa Rocket Pharmaceuticals saingan
TEM (Tempus AI) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QGEN (Qiagen)|Multiplikator P/S Ionis Pharmaceuticals, Inc. IONS|RGEN - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan RNA (Avidity Corp)|CRISPR Therapeutics AG (CRSP) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan genedx.com|RARE (Ultragenyx) - Multiplikator P/S|Multiplikator P/S Beam Therapeutics Inc|Multiplikator P/S SRPT|Kapitalisasi marang pendapatan Twist Bioscience Corp TWST|Multiplikator P/S TXG (10x Genomics, Inc.)|intelliatx.com (NTLA) - Rega marang dodolan|STOK: Kapitalisasi marang pendapatan|BLFS - Multiplikator P/S|WVE (Wave Life Sciences Corp) - Kapitalisasi marang pendapatan|MAZE: Kapitalisasi marang volume dodolan|SION (Sionna Therapeutics Inc) - Multiplikator P/S|primemedicine.com (PRME) - Koefisien rega marang pendapatan|Multiplikator P/S TSHA|Kapitalisasi marang pendapatan uniQure NV QURE|Multiplikator P/S MGTX (MeiraGTx PLC)|Multiplikator P/S REGENXBIO Corp RGNX|SLDB - Rasio rega marang pendapatan|OCGN: Rasio rega marang pendapatan|PacBio (PACB) - Rasio rega marang pendapatan|BNTC - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Design Pharma|FDMT: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S LXEO|Kapitalisasi marang pendapatan korrobio.com KRRO|Rasio rega marang pendapatan Editas Medicine EDIT|Multiplikator P/S Silence Therapeutics PLC SLN|PRQR: Kapitalisasi marang pendapatan|Codexis, Inc. - Kapitalisasi marang volume dodolan|SGMO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan NAUT|Rasio rega marang pendapatan Metagenomi|Rasio kapitalisasi marang pendapatan DTIL (precisionbiosciences.com)|Multiplikator P/S GBIO|Multiplikator P/S Boundless Bio Inc (BOLD)|Rasio rega marang pendapatan Exicure XCUR|Rasio kapitalisasi pasar marang pendapatan IMNN|PHIO - Rasio rega marang pendapatan|Rega marang dodolan Mustang Bio, Inc.|RNAZ: Multiplikator P/S|Kapitalisasi marang pendapatan Bionano Genomics|Rasio rega marang pendapatan Applied DNA Sciences|Multiplikator P/S bluebirdbio.com|Multiplikator P/S IPA|OMGA - Rega marang dodolan|Singular Genomics Systems Inc - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan RGLS (Regulus)|SYRS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan TBIO (telesisbio.com)|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Rasio rega marang dodolan UBX (Unity Biotechnology Inc.)
